SILO PHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 43.1% | 43.1% | 37.2% |
| FY2022 | -37.8% | -37.8% | -33.6% |
| FY2023 | -59.9% | -59.9% | -47.8% |
| FY2024 | -87.3% | -87.3% | -59.3% |
| FY2025 | -67.0% | -67.0% | -55.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 43.1% | 43.1% | 37.2% |
| FY2022 | -37.8% | -37.8% | -33.6% |
| FY2023 | -59.9% | -59.9% | -47.8% |
| FY2024 | -87.3% | -87.3% | -59.3% |
| FY2025 | -67.0% | -67.0% | -55.6% |